Germany Biosimulation Market Size & Outlook, 2021-2028
Germany biosimulation market, 2016-2028 (US$M)
Related Markets
Germany biosimulation market highlights
- The Germany biosimulation market generated a revenue of USD 135.6 million in 2021 and is expected to reach USD 348.0 million by 2028.
- The Germany market is expected to grow at a CAGR of 14.4% from 2022 to 2028.
- In terms of segment, software was the largest revenue generating product in 2021.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Biosimulation market data book summary
| Market revenue in 2021 | USD 135.6 million |
| Market revenue in 2028 | USD 348.0 million |
| Growth rate | 14.4% (CAGR from 2021 to 2028) |
| Largest segment | Software |
| Fastest growing segment | Software |
| Historical data | 2016 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Services |
| Key market players worldwide | Certara Inc Ordinary Shares, Dassault Systemes SE, Avantium NV, Simulations Plus Inc, Schrodinger Inc Ordinary Shares, Chemical Computing Group, Physiomics, Rosa & Co, Genedata AG, Instem, Yokogawa Electric Corp., Immunetrics |
Other key industry trends
- In terms of revenue, Germany accounted for 5.6% of the global biosimulation market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, Germany biosimulation market is projected to lead the regional market in terms of revenue in 2028.
- UK is the fastest growing regional market in Europe and is projected to reach USD 290.2 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biosimulation Market Scope
Biosimulation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany biosimulation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biosimulation market will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 67.26% in 2021. Horizon Databook has segmented the Germany biosimulation market based on software, services covering the revenue growth of each sub-segment from 2016 to 2028.
Germany held the dominant share of Europe biosimulation market owing to high adoption of biosimulation software to optimize R&D activities for higher productivity and greater regulatory compliance, thus enabling expedited drug discovery and development process.
Furthermore, shorter product development cycle, improved organizational effectiveness, and greater access to advanced technology are among the additional benefits provided by biosimulation.
Several prominent pharmaceutical companies have their R&D facilities in the country. Furthermore, these industry players often collaborate with academic research institutes and universities for conducting clinical trials. These benefits are expected to drive the preference for biosimulation in Germany.
Reasons to subscribe to Germany biosimulation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Germany biosimulation market databook
-
Our clientele includes a mix of biosimulation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany biosimulation market , including forecasts for subscribers. This country databook contains high-level insights into Germany biosimulation market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Germany biosimulation market size, by product, 2016-2028 (US$M)
Germany Biosimulation Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
